Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
. It may aim to level the playing field with one competitor in particular: Amazon.
LVMH shares fell 3.7% after it announced that sales at its core division fell for the first time since 2020.
Diamond Sports wants to rebrand its portfolio of local Bally Sports regional sports networks (RSNs) and rebrand them.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Google is revamping its shopping service into a more Instagram-slash-TikTok-esque feed, showing users an infinite scroll of products.
Bausch + Lomb has stirred up significant interest from the pair of private equity giants, TPG and Blackstone.
Executives believe the market for electric vehicles is about to see a rebound in demand as prices come down.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Gritstone Bio announced it is “taking action” to “preserve value and strengthen capital structure” on Thursday.
As the takeover bid from Couche-Tard heats up, Seven & i Holdings announced a plan to split its business in two.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.